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Abstract Hemodynamic forces play a fundamental role in the
regulation of endothelial cell survival. As signaling via the vas-
cular endothelial growth factor (VEGF) receptor-2 pathway has
been previously demonstrated to impact endothelial cell survival,
we hypothesized that laminar shear stress may facilitate survival
in part by inducing VEGF receptor-2 expression. This study
shows a time- and dose-dependent upregulation of endothelial
VEGF receptor-2 expression by £uid shear stress in microvas-
cular and large-vessel derived endothelial cells. A functional
analysis of the 5P-regulatory region of the VEGF receptor-2
promoter localized the shear stress-response element to a se-
quence between bp 360 and 337 that encompasses two adjacent
consensus Sp1 transcription factor binding sites. Constitutive
and shear stress-inducible Sp1-dependent complexes are bound
to this element, indicating that £uid shear stress-induced tran-
scriptional activation of the VEGF receptor-2 gene requires
Sp1-dependent DNA binding. Together, these results suggest
that biomechanical stimulation may lead to endothelial cell sur-
vival by upregulating VEGF receptor-2 expression.
2 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Physiological and pathological vessel formation is regulated
by complementary and coordinated signaling between di¡er-
ent growth factors and their receptors [1]. Within the family
of endothelium-speci¢c polypeptide growth factors, vascular
endothelial growth factor (VEGF, currently also referred to as
VEGF-A) is viewed as a prime regulator of blood vessel
growth by vasculogenesis and angiogenic sprouting [2].
VEGF is known for its ability to induce vascular perme-
ability, to promote endothelial proliferation and migration,
and to act as a critical survival factor for endothelial cells
[3,4]. Two structurally related receptor tyrosine kinases,
VEGF receptor-1 (VEGFR1, originally known as Flt-1) and
VEGF receptor-2 (VEGFR2, formerly termed KDR/Flk-1),
are predominantly involved in initiating signaling cascades
in response to VEGF [5]. Whereas VEGFR1 may mainly
act in a negative fashion by inhibiting VEGFR2 signaling or
by functioning as a decoy receptor [6,7], VEGFR2 is thought
to mediate the major permeability and growth e¡ects of
VEGF [8,9].
While VEGF is secreted by various di¡erent cell types,
VEGFR2 expression is largely restricted to vascular endothe-
lial cells [10]. In the adult, VEGFR2 is only detectable at
relatively low amounts in the vasculature [9,11]. However,
VEGFR2 may be markedly upregulated by blood vessels dur-
ing tumor growth, wound repair, and in in£ammatory dis-
eases [12,3]. At the same time, VEGFR2 expression closely
correlates with VEGF expression in angiogenic responses.
Therefore, suppression of the VEGF/VEGFR2 signaling path-
way is being intensely explored as attractive therapeutic ave-
nue to interfere with new blood vessel formation [13].
The coordinated regulation of VEGFR expression is critical
for blood vessel formation and angiogenic remodeling [2].
Yet, the stimuli and mechanisms of VEGFR regulation are
only partially understood. Whereas hypoxia appears to induce
both VEGFR1 and VEGFR2 in vivo [14,15], VEGFR2 ex-
pression is not a¡ected by hypoxia in vitro [16,17]. Thus, a
paracrine mode via VEGF expression has been proposed, as
culture media from hypoxic cells may induce VEGFR2 pro-
tein [16], and since VEGF treatment has been shown to induce
VEGFR2 expression in cerebral slide cultures [18]. However,
this assumption remains controversial, as di¡erent in vitro
studies fail to show upregulation of VEGFR2 expression in
response to VEGF [19,20]. In addition, basic ¢broblast
growth factor appears to increase VEGFR2 expression
[20,21], whereas tumor necrosis factor-K [22] and transforming
growth factor-L1 [23] seem to downregulate VEGFR2 expres-
sion.
Increased recognition of biomechanical forces as critical
stimuli for maintenance of vascular integrity and microvascu-
lar remodeling has created great interest in cellular mecha-
nisms that link changes in gene expression to shear stress
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stimulation [24,25]. We hypothesized that laminar shear stress
may facilitate endothelial cell survival by inducing VEGFR2
expression, as £uid shear stress may provide a critical survival
stimulus and has been implicated in microvascular remodeling
previously [26,27].
The present study reveals that exposure of endothelial
monolayers to £uid shear stress induces VEGFR2 expression
in a time- and dose-dependent fashion. To determine molec-
ular mechanisms responsible for shear stress-mediated
VEGFR2 gene transcription, we utilized 5P-deletional and mu-
tational VEGFR2 promoter-based constructs in transcription-
al activation studies. A shear stress-response element was lo-
calized to a bp 360/337 region that contains two adjacent
consensus Sp1 transcription factor binding sites. Subsequent
electrophoretic mobility shift assays (EMSAs) showed consti-
tutive Sp1-site-dependent complex formation which was in-
ducible upon shear stress exposure. Thus, £uid shear stress-
induced transcriptional activation of the VEGFR2 gene is
shown to require Sp1-dependent DNA binding.
2. Materials and methods
2.1. Cell culture
Pooled human umbilical vein endothelial cells (HUVECs) and hu-
man dermal microvascular endothelial cells (HDMECs) were pur-
chased from PromoCell (Heidelberg, Germany) and cultured at
37‡C and 5% CO2 in Endothelial Basal Medium MV (PromoCell),
supplemented with hydrocortisone (1 Wg/ml), gentamicin (50 Wg/ml),
amphotericin B (50 ng/ml), epidermal growth factor (10 ng/ml), and
5% fetal calf serum (FCS) until the ¢fth passage. After detachment
with trypsin, 3.0U105 cells were seeded in 60-mm cell culture dishes
for 24 h, and were then rendered quiescent by changing to medium
containing 1% FCS. HUVECs or HDMECs were exposed to laminar
£uid £ow in a cone-and-plate apparatus as previously described
[28,29]. A constant shear stress of 5, 15, or 45 dynes/cm2 was used
to simulate physiological levels of shear stress.
2.2. Western blot analysis
After exposure to shear stress, endothelial cells were washed twice
with cold phosphate-bu¡ered saline, lysed in cold bu¡er containing 20
mM HEPES, 150 mM NaCl, 0.2% Triton X (v/v), 10% glycerol (v/v),
supplemented with proteinase inhibitors antipain (2 Wg/ml), aprotinin
(2.2 Wg/ml), pepstatin A (1 Wg/ml), leupeptin (2 Wg/ml) and phenyl-
methylsulfonyl £uoride (1 mM, all from Sigma Chemicals, Deisenho-
fen, Germany), for 30 min on ice. Protein concentrations were deter-
mined with the DC Protein Standard Assay (Bio-Rad, Munich,
Germany). Samples containing equal amounts of protein (V10 Wg/
lane) were boiled at 95‡C for 3 min, were then subjected to 8% SDS^
polyacrylamide gel electrophoresis (PAGE) and transferred to poly-
vinylidene £uoride membranes (Millipore, Eschborn, Germany) at
50 V, and subsequently blocked in Tris-bu¡ered saline^Tween 20
containing 5% non-fat milk. The membranes were incubated with
the indicated primary antibodies (VEGFR1, clone H-225, VEGFR2,
clone A-3, from Santa Cruz Biotechnology, Heidelberg, Germany;
Tubulin Ab from LabVision Ltd., Newmarket Su¡olk, UK), followed
by incubation with horseradish peroxidase-conjugated secondary anti-
bodies (anti-mouse or anti-rabbit IgG, Amersham Biosciences, Frei-
burg, Germany). The blots were developed using the enhanced chemi-
luminescence (ECL) detection system according to the instructions of
the manufacturer (Amersham).
2.3. Quantitative real-time RT-PCR
Total cellular RNA was isolated from cell cultures grown in 6-well
plates by the RNeasy Mini Procedure (Qiagen, Hilden, Germany)
after homogenization of cell lysates using the QIAshredder (Qiagen).
The LightCycler0-RNA Master SYBR Green I kit was employed for
one-step RT-PCR using the LightCycler0 Instrument (Roche Molec-
ular Biochemicals, Mannheim, Germany). The reaction mixture con-
tained 100 ng of RNA, oligo primer at 0.4 WM each, and Mn(OAc)2
at 3.25 mM in a total volume of 20 Wl. The experimental protocol was
adapted to use with the LightCycler0-Control Kit RNA (Roche) as
outlined by the supplier. The primers (all from TIB Molbiol, Berlin,
Germany) spanning speci¢c exon boundaries were as follows:
VEGFR2 as target gene, 5P-ATGCTCAGCAGGATGGAA-3P (Gen-
Bank accession number AF035121; corresponding to 3803^3821) and
5P-TTTGGTTCTGTCTTCCAAAGTT-3P (4134^4113); human glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) as reference gene,
5P-GAAGGTGAAGGTCGGAGTC-3P (GenBank accession number
BC025925, corresponding to 63^81) and 5P-GAAGATGGTGATGG-
GATTTC-3P (269^288). As external standard method, a common
standard curve was obtained by the LightCycler0-Control Kit RNA
(Roche) that was included in each LightCycler0 run. The standard
curve was used to determine the concentration of the VEGFR2 and
GAPDH gene. The similar calculated melting temperatures for all
primers enabled the use of the same cycling program for all samples.
2.4. Plasmids
Reporter constructs containing 5P-regulatory sequences of the hu-
man VEGFR2 gene have been described previously [30]. Brie£y, the
sequences were inserted into pGL2-Basic vector (Promega, Madison,
WI, USA) and named according to the length of the fragment (from
the transcription start site) in the 5P and 3P directions (34kb/+296,
3164/+268, 377/+268). The encompassing sequence for the 360/+268
construct has been ampli¢ed by PCR technique with £anking 5P-Hin-
dIII and 3P-XhoI enzyme restriction sites to facilitate directional clon-
ing into the pGL2-Basic vector. The construct carrying two-nucleotide
(2-nt) mutations (CCCAA) within the Sp1 consensus sites (360 m/
+268) was generated identically, except that a primer was used which
included the respective 2-nt mutations. All constructs were sequenced
from the 5P- and 3P-ends to con¢rm orientation and sequence correct-
ness.
2.5. Transient transfection and analysis of reporter gene expression
HUVECs (3.5U105, seeded in 60-mm dishes) were transfected with
3 Wg of appropriate ¢re£y luciferase (Luc) construct and 0.6 Wg pRL-
TK vector (as internal control Renilla Luc vector to normalize for
transfection e⁄ciency; Promega) using SuperFect Transfection Re-
agent (Qiagen, Hilden, Germany). Fourty-eight hours after transfec-
tion, control transfectants were left untreated (static controls) and test
transfectants were exposed to shear stress (15 dynes/cm2) for 24 h.
The activities of ¢re£y and Renilla Lucs were measured sequentially
from a single sample by the Lumat LB 9507 (Berthold Technologies,
Bad Wildbad, Germany), utilizing the Dual-Luciferase0 Reporter As-
say System from Promega.
2.6. Preparation of nuclear extracts and gel mobility shift analysis
HUVECs were left untreated or were subjected to shear stress
for (15 dynes/cm2) for 24 h. Nuclear proteins were extracted as de-
scribed previously [31]. The oligonucleotides were synthesized to span
the region between 363 bp and 331 bp of the human VEGFR2
promoter: 5P-CGGCCCCGCCCCGCATGGCCCCGCCTCCGCGC-
T-3P. The mutated probe carried 2-nt mutations (CCCAA) within the
Sp1 consensus sites: 5P-CGGCCAAGCCCCGCATGGCCAAGCCT-
CCGCGCT-3P. The underlined sequences served as a template for
synthesis of the second strand. Radiolabeled double-stranded DNA
was synthesized by annealing an oligonucleotide complementary to
the underlined sequence listed above (5P-AGCGCGGAGGC-3P),
and by extension of the second strand with Klenow fragment, 50
WCi of [K-32P]dCTP, unlabeled dATP, dTTP and dGTP. Unincorpo-
rated nucleotides were removed by column chromatography. Cold
unlabeled double-stranded DNA was made identically except that
unlabeled dCTP was substituted for labeled dCTP. The DNA binding
reaction was performed for 30 min at room temperature in a volume
of 20 Wl, containing 5 Wg of nuclear protein extract, 2.5 mg/ml bovine
serum albumin, 105 cpm K-32P-labeled probe (V0.5^1.0 ng), 0.1 mg/
ml poly[dI:dC] (Sigma), 5 Wl of 4Ubinding bu¡er (1Ubu¡er: 10 mM
Tris^HCl, pH 7.8, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 10%
[v/v] glycerol, 1 mM DTT) with or without excess of unlabeled com-
petitor, Sp1 consensus-oligonucleotide (Promega), Sp1 or RelA/NF-
UB antibody (Santa Cruz). Samples were subjected to electrophoresis
on a native 4% PAGE for 2.5 h at 120 V.
2.7. Statistical analysis
Data are expressed as meanTS.D./S.E.M. from at least three inde-
pendent experiments. Statistical analysis was performed by Student’s
t-test.
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3. Results
3.1. Time- and dose-dependent upregulation of VEGFR2
expression by £uid shear stress in human endothelial cells
To examine the e¡ect of £uid shear stress on VEGFR2
regulation, HUVECs were exposed to shear stress for di¡erent
time intervals (Fig. 1A). Western blot analyses revealed a
substantial increase in VEGFR2 protein expression by 6 h,
which was further increased by 16 and 24 h. To explore
dose-dependent VEGFR2 induction in HUVEC, di¡erent
doses of shear stress were applied for 16 h (Fig. 1B). Marked
induction was seen in HUVECs exposed to shear stress of
5 dynes/cm2. Further upregulation of VEGFR2 protein ex-
pression was noticed after exposure up to 15 dynes/cm2. Shear
stress-mediated VEGFR2 induction was also demonstrable in
dermal microvascular endothelial cells (HDMECs, Fig. 1C).
Interestingly, VEGFR1 expression levels were essentially un-
a¡ected by shear stress exposure (Fig. 1D). In addition,
VEGFR2 transcript levels are increased in a time-dependent
fashion (Fig. 2). These results are in line with a recent report,
revealing VEGFR2 upregulation in response to 24 h shear
stress by DNA microarray analysis [32]. Hence, shear stress-
induced VEGFR2 expression may be mediated at the tran-
scriptional level. Together, our data demonstrate that £uid
shear stress represents a robust stimulus for VEGFR2 induc-
tion in endothelial cells from di¡erent origins.
3.2. Functional analysis of the 5P-regulatory region of the
VEGFR2 promoter in response to £uid shear stress
To determine molecular mechanisms responsible for shear
stress-regulated VEGFR2 gene transcription, a series of 5P-
deletional VEGFR2 promoter-based reporter gene constructs
was transiently transfected into HUVECs (Fig. 3). Analyses of
the respective Luc expressions in control and shear-stressed
cells revealed signi¢cant basal activity of the 34 kb/+296 bp
and 3164/+268 bp VEGFR2 Luc constructs that was in-
creased in response to shear stress by a factor of 2 to 2.5.
Shorter constructs, including the 377/+268 and the 360/
+268 bp VEGFR2 construct, showed less constitutive and
induced expression compared to the longer reporter plasmids,
however, considerable basal activity was retained, including
the ability to signi¢cantly enhance reporter gene activity
(2.0 T 0.5; P6 0.04). These ¢ndings suggest that key gene-reg-
ulatory elements necessary for both constitutive and shear
stress-inducible expression are located 3P of the 360 bp. The
signi¢cance of a Sp1 cluster in close proximity to transcription
start site has been demonstrated previously [30,33]. As two
adjacent Sp1 consensus binding sites are located at position
A B
C D
Fig. 1. VEGFR2 expression is regulated by shear stress in large vessel-derived and microvascular endothelial cells. A: Representative Western
blot analyses of HUVECs that were grown under static conditions or were exposed to laminar shear stress for 6, 16 or 24 h (15 dyne/cm2) or
(B) were exposed to di¡erent shear strengths (5, 15, 45 dyne/cm2) for 16 h. C: VEGFR2 protein expression by HDMECs either left untreated
or subjected to shear stress for 16 h (15 dyne/cm2). D: VEGFR1 protein expression by HUVECs that were grown under static conditions or
were exposed to laminar shear stress 16 h (15 dyne/cm2). Total cellular protein was separated by 8% SDS^PAGE. VEGFR1, VEGFR2 and tu-
bulin protein were detected by ECL. Comparable results were obtained from at least three independent experiments.
Fig. 2. VEGFR2 mRNA expression is induced by laminar shear
stress. HUVECs were grown under static conditions or exposed to
laminar shear stress for 6 or 24 h (15 dyne/cm2). Total cellular
RNA was isolated by the RNeasy Mini Procedure (Qiagen). Quanti-
¢cation of mRNA expression was accomplished by real-time Light-
Cycler0 RT-PCR using GAPDH expression as a reference against
which VEGFR2 transcript levels were normalized. An external stan-
dard curve obtained by the LightCycler0-Control Kit RNA (Roche)
was used to determine the concentration of VEGFR2 and GAPDH
gene transcripts. Normalized VEGFR2 mRNA level in HUVECs
grown under static conditions for 6 h was arbitrarily set at ‘1’. The
data are displayed as fold increase and represent the meanTS.E.M.
of three independent duplicate experiments (Student’s t-test;
P6 0.02).
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358 bp and 344 bp (Fig. 4), we next examined the potential
impact on transcriptional activation of a mutant 360/+268 bp
Luc construct, in which critical 2-nt mutations [34] were in-
corporated within the Sp1 sites (Fig. 3). Analyses of the mu-
tant 360/+268 bp construct showed loss of both basal and
shear stress-induced reporter gene expression. By comparison,
expression in control and shear-stressed HUVECs was equiv-
alent to that of the backbone vector alone. These data indi-
cate that basal and shear-mediated VEGFR2 transcription is
Sp1-site-dependent.
3.3. Constitutive and shear stress-inducible Sp1-dependent
binding activity to the 363/331 bp VEGFR2 promoter
sequence
We next explored whether speci¢c protein complexes could
be identi¢ed that interacted with the VEGFR2 promoter re-
gion which had been demonstrated to be important in our
transcriptional activation studies. We utilized a double-
stranded DNA probe corresponding to the 363/331 bp
VEGFR2 promoter sequence in electrophoretic mobility shift
assays (Fig. 4). When incubated with nuclear extracts of un-
treated HUVECs, constitutive DNA binding activity of two
distinct complexes was observed (lane 1). In lysates of cells
that had been exposed to £uid shear stress for 1 h, a signi¢-
cant increase in DNA binding activity was detected (lane 2).
These data indicate that shear stress augments constitutively
expressed protein complexes without inducing additional
DNA binding activity. The binding speci¢city of the com-
plexes was determined by competition through excess of un-
labeled identical DNA (lanes 5 and 6), but not Sp1-mutated
DNA (lanes 7 and 8). The complexes were also competed with
excess of unlabeled double-stranded Sp1 consensus oligonu-
cleotides (lanes 3 and 4), further supporting the assumption
that nuclear proteins bind to the 363/331 bp VEGFR2 pro-
moter sequence in a Sp1-site-exclusive manner. Addition of
Sp1 antibody led to formation of more slowly migrating com-
plexes (lane 10). An irrelevant antibody directed against RelA/
NF-UB, however, did neither a¡ect the complex formation nor
it induced a supershift (lane 9). Together, these ¢ndings pro-
vide strong evidence that shear stress-induced transcriptional
activation of the VEGFR2 gene is conferred by increased Sp1-
like binding activity to the GC-rich core promoter.
4. Discussion
New blood vessel formation and angiogenic remodeling
during in£ammation and tumor growth are associated with
a number of structural and hemodynamic changes. Besides
the action of di¡erent established humoral factors [2], there
is increasing evidence that biochemical stimulation of endo-
thelial cells plays a critical role in maintenance of vascular
integrity and microvascular remodeling [25]. However, infor-
mation on molecular mechanisms by which mechanical forces
impact pathological vascular remodeling is still limited.
The vasculature in in£ammatory processes and tumors is
functionally and structurally abnormal, presenting in part
with excessive shunts and disproportionate branches [35]. Un-
even diameters as a result of dilated and tortuous vessel ar-
chitecture lead to variable and disordered blood £ow [36,37].
Since £uid shear stress may act as a critical survival stimulus
and has been implicated in microvascular remodeling previ-
ously [26,27], we hypothesized that laminar shear stress may
facilitate endothelial cell survival by inducing VEGFR2 ex-
pression. This assumption is bolstered by accumulating data,
Fig. 3. The shear stress-responsive region is localized between bp 360 and 337 of the VEGFR2 gene promoter. Analyses of 5P-deletional and
mutational VEGFR2 promoter-based Luc constructs in HUVECs. Schematic representation of the respective reporter gene constructs on the
left, coordinates with respect to the transcription start site in the center, and the relative Luc activities (expressed as % basal activity of the
3164/+268 construct) in graphic format on the right: white bars, static controls (Ctrl.) ; black bars, shear stress-subjected cells (meanTS.D. of
three independent duplicate assays); the fold increase in Luc activity after shear stress exposure is depicted to the right (meanTS.D. of three
independent duplicate transfections and assays).
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closely linking the VEGF/VEGFR2 signaling pathway to en-
dothelial cell survival both in vitro and in vivo [5].
The present study demonstrates that shear stress acts as a
powerful stimulus for VEGFR2 expression by microvascular
(HDMEC) and large vessel-derived endothelial cells (HU-
VEC). While our manuscript was in preparation, Abumiya
and co-workers [38] reported on shear stress e¡ects being
comparable to ours with regard to VEGFR2 protein induc-
tion. In line with their data, we observed a strength- and time-
dependent VEGFR2 regulation in HUVECs. Induction of
VEGFR2 mRNA expression peaks at 6^8 h, whereas maximal
protein expression is seen after 16^24 h.
As a major control point of gene expression, transcriptional
activation has been previously identi¢ed as a key regulatory
mechanism of VEGFR2 expression [39,40,41]. We thus exam-
ined VEGFR2 gene transcriptional regulation in response
to laminar shear stress within HUVECs. In our analyses of
5P-deletional and mutational reporter gene constructs, a core
promoter region was identi¢ed that confers shear stress-me-
diated transactivation of the VEGFR2 gene. This GC-rich
region between bp 360 and 337 contains two adjacent con-
sensus Sp1 transcription factor binding sites and was
subsequently utilized as a DNA probe in EMSAs. These ex-
periments showed constitutive Sp1-site-dependent complex
formation which was signi¢cantly induced in response to lam-
inar shear stress.
In 5P-deletional analyses, Abumiya et al. localized the shear
stress-responsive element to a VEGFR2 promoter region be-
tween bp 394 and 331 [38]. Previous site-speci¢c mutation
studies in bovine retinal endothelial cells found an atypical
Sp1-like binding site (bp 374/370) to be important for basilar
VEGFR2 promoter activity [42]. Guided by these ¢ndings,
Abumiya and co-workers evaluated the impact of a 3-nt mu-
tation (TCCCAAG at bp 373/371) on shear stress-induced
transcriptional activity. While baseline activity was modestly
reduced, shear stress-mediated induction of a 394/+265 bp
VEGFR2 promoter construct was seen to be lost through
incorporation of the 3-nt mutation [38]. In our studies, how-
ever, deletion from bp 377 to 360 retained the capacity to
induce shear stress-driven VEGFR2 promoter activity (Fig. 3).
Only when critical 2 nt-mutations were introduced into the
consensus Sp1 sites, both basal and shear stress-induced re-
porter gene expression of the 360/+268 bp VEGFR2 con-
struct were lost. Thus, our data clearly di¡er from the work
by Abumiya et al. as to the precise localization of the shear
stress-response element.
Contrary to our EMSA analyses, Abumiya and co-workers
detected shear stress-induced Sp1-like binding activity merely
to a CT-rich 385/364 bp DNA probe, but not to double-
stranded Sp1 consensus oligonucleotides [38]. However, our
EMSA studies revealed constitutive and shear stress-inducible
Sp1-site-dependent complex formation to the 363/331 bp
Fig. 4. Constitutive and shear stress-inducible Sp1-site-dependent DNA binding activity of HUVEC nuclear protein extracts to the 363/331 bp
VEGFR2 promoter sequence. Representative EMSAs using nuclear extracts of untreated (lanes 1, 3, 5 and 7) and shear-stressed HUVECs
(lanes 2, 4, 6, 8, 9 and 10); competition with unlabeled excess double-stranded Sp1 consensus oligonucleotides (lanes 3 and 4; at a ¢nal concen-
tration of 0.35 WM), or with unlabeled 363/331 bp wild-type DNA (lanes 5 and 6; at 100 M excess), or with a mutated unlabeled 363/331
bp DNA oligo (lanes 7 and 8; at 100 M excess) in which critical 2-nt changes were incorporated within the Sp1 sites. Supershift analyses were
performed by addition of speci¢c RelA/NF-UB or Sp1 antibody (Santa Cruz) at a ¢nal concentration of 100 ng/Wl (lanes 9 and 10). The DNA
sequence of the utilized probe is shown at the top (Sp1 sites in bold), the formation of Sp1-dependent binding complexes is indicated by arrows
to the left, supershifted complexes are marked by a bold arrow to the right.
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VEGFR2 promoter sequence (Fig. 4). This region, which has
been shown to be functionally important in our transcription-
al activation assays (Fig. 3), contains two adjacent Sp1 bind-
ing sites. Basal and shear stress-induced DNA binding activity
was entirely competed with excess unlabeled Sp1 consensus
oligonucleotides, but not with a mutated unlabeled 363/331
bp DNA probe in which the critical 2-nt changes were incor-
porated in the Sp1 sites. Our ¢ndings are in line with previous
observations on nuclear protein interactions with the
VEGFR2 promoter by in vitro DNase I footprint analyses,
in which the protection pattern produced by HUVEC nuclear
extracts could be fully mimicked through recombinant Sp1
protein alone [33]. Together, the data presented herein ¢rmly
support the assumption that essential cis-acting elements for
shear stress-mediated VEGFR2 transcription reside within the
360/337 bp sequence.
The VEGFR2 promoter lacks a TATA sequence motif [30].
Thus mechanisms other than direct recruitment of TATA-
binding proteins are required for positioning of the basal tran-
scription complex and initiation of transcription from a de¢-
nite site. In particular, Sp1 transcription factors have been
shown to function as key proteins in accurate transcription
initiation from TATA-less promoters [43]. These mechanisms
appear to apply for the VEGFR2 promoter as well, as our
studies show that mutation of the two most 3P Sp1 binding
sites decreased both basal and induced Luc expression to lev-
els comparable to those obtained by parent vector only.
Several diverse e¡ects of hemodynamic forces on vascular
cells have been identi¢ed in recent years [25], including rapid
protein phosphorylation and cytoskeletal rearrangement
[29,44]. In addition, endothelial cells have been shown to
adapt to £uid biochemical stress by changes in gene expres-
sion [24,45]. Characterization of shear stress-response ele-
ments in promoters of reactive genes provided an enhanced
understanding of cellular mechanisms that link gene regula-
tory events to shear stress stimulation. Pertinent to these ¢nd-
ings, transcription factor Sp1 has been previously implicated
in shear stress induction of the tissue factor gene [46]. In the
absence of shear stress-induced binding activity to a Sp1-site
cluster within the tissue factor promoter, phosphorylation of
Sp1 was proposed as a mean to increase transcriptional activ-
ity. While our study di¡ers from the recent report by Abu-
miya et al. as to the precise localization of the shear stress-
responsive region in the VEGFR2 promoter [38], both studies
showed increased Sp1-like activity in nuclear extracts from
shear-stressed HUVECs. Hence, Sp1-like binding sites may
serve as shear stress-response elements that are also transacti-
vated via increased DNA binding activity.
Together, the present study suggest that shear stress, an
important driving force in vascular remodeling and restructur-
ing of blood vessels, contributes to endothelial cell survival in
part by inducing VEGFR2 expression. Our ¢ndings implicate
Sp1-site-dependent DNA binding in £uid shear stress-induced
transcriptional activation of the VEGFR2 gene. The involve-
ment of hemodynamic forces in endothelial cell survival may
potentially explain as to why adjacent vessel sections di¡er in
their extent to respond to soluble angiogenic factors.
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